Dose Safety, Tolerability, and Immunogenicity of a New Smallpox Vaccine in Adults Without Previous Smallpox Vaccination

This study has been terminated.

(CDC's decision to down-select vaccine development to single candidate, ACAM2000)

Sponsor:

Information provided by:

Sanofi

ClinicalTrials.gov Identifier:

NCT00053508

First received: January 30, 2003

Last updated: January 14, 2009

Last verified: January 2009

No Study Results Posted on ClinicalTrials.gov for this Study

Study Status:	This study has been terminated.
Study Completion Date:	September 2003
Primary Completion Date:	March 2003 (Final data collection date for primary outcome measure)